Sequenom Announces Participation At The Jefferies Global Healthcare Conference

Sequenom Announces Participation At The Jefferies Global Healthcare Conference

PR Newswire

SAN DIEGO, May 28, 2013

SAN DIEGO, May 28, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life
sciences company providing innovative diagnostic testing and genetic analysis
solutions, today announced the Company's participation at the Jefferies 2013
Global Healthcare Conference at the Grand Hyatt in New York, NY on June 3-6,

Harry F. Hixson, Jr., Ph.D., Chairman and CEO, will present on Tuesday, June
4, 2013, beginning at 11:30 a.m. ET, to provide an overview of and update on
the Company. The presentation is expected to last approximately 30 minutes
and will be webcast live through the "Investors" section of the Sequenom
website at An audio replay will be available for 30 days
following the initial presentation webcast. 

About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular diagnostics
markets. The company was founded in 1994 and is headquartered in San Diego,
California. Sequenom maintains a Web site at to which
Sequenom regularly posts copies of its press releases as well as additional
information about Sequenom. Interested persons can subscribe on the Sequenom
Web site to email alerts or RSS feeds that are sent automatically when
Sequenom issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the Web site.


SOURCE Sequenom, Inc.

Contact: Marcy Graham, Senior Director, Investor Relations & Corp Comm,
Sequenom, Inc., 858-202-9028,, and Jakob Jakobsen, Media
Contact, Chandler Chicco Agency, 310-309-1003,
Press spacebar to pause and continue. Press esc to stop.